Ensuring Trust, Security, and Regulatory Excellence

At Viventis, we are committed to upholding the highest standards of data privacy, security, and regulatory compliancein AI-powered cancer treatment and gene-based therapies. We prioritize patient safety, ethical AI practices, and adherence to global and Indian healthcare regulations to drive responsible innovation in oncology.

Privacy Policy & Data Security Practices

Commitment to Data Protection

We follow strict data privacy laws to safeguard patient and research data. Our systems comply with:
✔ General Data Protection Regulation (GDPR) – European Union
✔ Health Insurance Portability and Accountability Act (HIPAA) – USA
✔ Digital Personal Data Protection Act (DPDP) – India

How We Protect Your Data

• End-to-End Encryption: Ensuring secure storage and transmission of patient records.

• De-Identification & Anonymization: Removing personal identifiers from AI datasets to protect user privacy.

• Role-Based Access: Allowing only authorized personnel to access sensitive data.

• Regular Security Audits: Continuous monitoring and compliance checks to prevent data breaches.

Regulatory Compliance

Global & Indian Healthcare Regulations

Viventis adheres to strict regulatory guidelines to ensure the safety, efficacy, and ethical application of AI-driven drug discovery and gene-based therapies.

✅ FDA (Food & Drug Administration, USA) – Compliant with AI-driven drug discovery and gene therapy approval frameworks.
✅ EMA (European Medicines Agency) – Meets stringent regulations for clinical trials and biotech innovations.
✅ ICMR (Indian Council of Medical Research) Guidelines – Ensuring ethical AI use and gene-editing practices in India.
✅ CDSCO (Central Drugs Standard Control Organization, India) – Compliance with India's drug approval process.
✅ NABH (National Accreditation Board for Hospitals & Healthcare Providers, India) – Standards for patient safety in AI-driven healthcare.

AI in Healthcare: Ethical & Legal Considerations

• Transparency in AI Decisions: Ensuring explainability in treatment recommendations.

• Bias-Free AI Models: Continuous monitoring to prevent biases in AI-driven treatment plans.

• Ethical Use of Genomic Data: AI models adhere to bioethics guidelines for genetic research and modifications.

Terms & Conditions for AI Data Usage

AI-Powered Insights & Limitations

• Clinical Decision Support, Not Replacement: Our AI-driven treatment recommendations assist oncologists but do not replace professional medical judgment.

• Consent-Based Data Usage: Patient genomic data is only used for AI model improvements with explicit consent.

• Restricted Data Sharing: We do not sell or share patient data with third parties without regulatory approval.

Biopharma & Research Collaboration Terms

• Non-Disclosure Agreements (NDAs): Protecting sensitive research data in AI-based drug discovery partnerships.

• Data Ownership & Usage Rights: Ensuring ethical and legally compliant AI model training on oncology datasets.

• Intellectual Property Protection: Securing innovations in AI-driven cancer treatment and gene therapies.

Commitment to Responsible Innovation

Viventis is dedicated to responsible AI, ethical gene therapy, and strict regulatory compliance. We continuously update our policies to align with evolving healthcare regulations in India and globally.

📩 For compliance inquiries, contact our Legal Team at [legal@viventis.in].